| Revisions to labeling requirements for blood and blood components, including source plasma. Final rule. | |
| | |
MedLine Citation:
|
PMID: 22242229 Owner: HSR Status: In-Process |
Abstract/OtherAbstract:
|
The Food and Drug Administration (FDA) is revising the labeling requirements for blood and blood components intended for use in transfusion or for further manufacture by combining, simplifying, and updating specific regulations applicable to labeling and circulars of information. These requirements will facilitate the use of a labeling system using machine-readable information that would be acceptable as a replacement for the ``ABC Codabar'' system for the labeling of blood and blood components. FDA is taking this action as a part of its efforts to comprehensively review and, as necessary, revise its regulations, policies, guidances, and procedures related to the regulation of blood and blood components. This final rule is intended to help ensure the continued safety of the blood supply and facilitate consistency in labeling. |
| | |
Authors:
|
|
Related Documents
:
|
16084429 - Assessment of myocardial perfusion by dynamic n-13 ammonia pet imaging: comparison of 2... 1516269 - Failure of the nitrous oxide tissue equilibration method for the determination of brain... 624149 - Regional myocardial blood flow after sudden aortic constriction in awake dogs. 9663539 - Warm blood hyperkalaemic reperfusion ('hot shot') prevents myocardial substrate derange... 8888059 - Troponin t release with warm and cold cardioplegia. 10548789 - Characterization of t1 relaxation and blood-myocardial contrast enhancement of nc100150... 16998639 - A novel method of endoscopic mucosal resection assisted by submucosal injection of auto... 11547539 - Cerebral autoregulation and outcome in acute brain injury. 16354279 - Rheopheresis in patients with critical limb ischemia--results of an open label prospect... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Federal register Volume: 77 ISSN: 0097-6326 ISO Abbreviation: Fed Regist Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-01-13 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7808722 Medline TA: Fed Regist Country: United States |
Other Details:
|
Languages: eng Pagination: 7-18 Citation Subset: T |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Medical devices; ovarian adnexal mass assessment score test system; labeling; black box restrictions...
Next Document: Tribal child welfare. Interim final rule.